Key result
High-dose intracoronary adenosine escalation increased the positive rate of FFR assessments compared to conventional doses.
Why the study?
The recommended dosage of intracoronary adenosine in FFR assessment is controversial, and high-dose adenosine may overcome biological variability in hyperemic response.
Does a high-dose intracoronary adenosine escalation protocol increase the positive rate and accuracy of FFR assessment compared to conventional doses in patients undergoing FFR?
Observational (n=87)
No
Does a high-dose intracoronary adenosine escalation protocol increase the positive rate and accuracy of FFR assessment compared to conventional doses in patients undergoing FFR?
High-dose intracoronary adenosine escalation increases the proportion of positive FFR assessments but does not improve diagnostic accuracy compared to non-invasive testing.
Answers are grounded in this paper and cite their sources.
High-dose adenosine may raise positive FFR rates without accuracy gains; leaves open whether escalation improves outcomes or warrants practice change.
Background: The recommended dosage of intracoronary adenosine in fractional flow reserve (FFR) assessment is controversial. High-dose adenosine may overcome the biological variability of adenosine response in hyperemia. Objectives: We aimed to test the efficacy and safety of a high-dose escalation protocol at our institute. Methods: Using the adenosine dose escalation protocol, the percentages of FFR ≤ 0.75 and 0.80 after high-dose escalation were compared with those at conventional doses. The chi-squared test was used to evaluate the accuracy of FFR values with the tested doses by comparing them with the results of a non-invasive pretest. Results: A total of 87 patients (130 vessels) were included, and protocol adherence was 93.1%. High-dose intracoronary adenosine was injected in 78.5% of the vessels. The dose escalation strategy was well-tolerated without serious complications. The positive rate increased significantly after conducting the protocol compared to that with a conventional dose (28.2% vs. 23.6% with an FFR threshold of 0.75, and 48.7% vs. 42.5% with a threshold of 0.80, both p < 0.05). In the validation cohort, only FFR ≤ 0.75 was associated with the binary result of the non-invasive pretest (p < 0.01 vs. p = 0.37). The high-dose adenosine escalation strategy did not increase the accuracy of FFR (77.8% vs. 75.6% in conventional dose and high-dose adenosine, respectively). Conclusions: The use of a high-dose escalation strategy increased the positive rate in FFR assessments.
No takes yet. Share an insight, caveat, or question.
Liao et al. (2022) conducted an observational in Fractional flow reserve (FFR) assessment (n=87). High-dose intracoronary adenosine vs. Conventional dose was evaluated on Positive rate of FFR (threshold ≤ 0.80) (p=<0.05). High-dose intracoronary adenosine escalation increased the positive rate of FFR assessments compared to conventional doses.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: